Aequus Pharmaceuticals Inc.
AQSZFOTCHealthcare● Active
$0.00
+$0.00(+136.36%)
Market Cap$344850
P/E Ratio—
52W High$0.008
52W Low$0.0001
Aequus Pharmaceuticals Inc. (AQSZF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AQSZF · earnings · updated Jun 10, 2026
Latest Earnings
Q4 FY2025Report Date: Dec 1, 2025EPS Actual
$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Dec 1, 2025
After Market Close
AQSZF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 8, 2026 | — | — | — | — | — | — |
| — Q4 FY2025 | Dec 1, 2025 | — | $0.00 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 27, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | May 21, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | Apr 24, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Aug 29, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | May 9, 2024 | — | -$0.00 | — | $0.00B | — | — |
Q2 FY2026
Jun 8, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Dec 1, 2025
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 27, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 21, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Apr 24, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 8, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Aug 29, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 9, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for AQSZF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2025 | Dec 1, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q3 FY2025 | Aug 27, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2025 | May 21, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2025 | Apr 24, 2025 | — | $0.00 | $0.00 | +33.33% |
| — Q4 FY2024 | Nov 8, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2024 | Aug 29, 2024 | — | $0.02 | $0.02 | +0.00% |
| — Q2 FY2024 | May 9, 2024 | — | $0.01 | $0.01 | +56.42% |
| — Q2 FY2024 | Apr 29, 2024 | — | No price data | $0.01 | — |
Q4 FY2025+0.00%
Report Date
Dec 1, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2025+0.00%
Report Date
Aug 27, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2025+0.00%
Report Date
May 21, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2025+33.33%
Report Date
Apr 24, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2024+0.00%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q2 FY2024+56.42%
Report Date
May 9, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2024—
Report Date
Apr 29, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.01
Beat Rate0 / 8 quarters
Largest Move+56.42% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AQSZF ends December
Aequus Pharmaceuticals Inc. (AQSZF) most recently reported earnings on December 1, 2025 for Q4 FY2025, posting EPS of $0.00 (in line with the analyst consensus of —).
Each quarter, investors track AQSZF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AQSZF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AQSZF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AQSZF earnings · 4 questionsAequus Pharmaceuticals Inc.'s next earnings report is expected around TBD. AQSZF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AQSZF historically reports after market close (AMC).
AQSZF earnings datewhen is AQSZF earningsAQSZF next earnings datewhen does AQSZF report earningsAQSZF earnings calendar
▸ Source: FMP · Aequus Pharmaceuticals Inc. SEC filings · US GAAP · Aequus Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026